GlassScriptPhysician profile
Brian J Deignan
NPI 1710184098
$5,756.27
in general payments reported to CMS, 2019-2025
30 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,658 · 2020: $285 · 2021: $73.25 · 2022: $313 · 2023: $399 · 2024: $2,824 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,561 · Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,561.44 |
| Food and Beverage | $866.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,592.08 | 2024 | Integra, Acell, Primatrix |
| Biomarin Pharmaceutical INC. | $1,011.49 | 2019-2024 | Voxzogo 1.2mg |
| Stryker Corporation | $427.95 | 2019-2023 | Easyfuse, T2 |
| Orthopediatrics Corp. | $349.13 | 2020-2022 | |
| Medical Device Business Services, INC. | $237.42 | 2019-2024 | Expedium |
| Orthofix Medical, INC. | $155.86 | 2023-2025 | Fitbone, Spinal-Stim, Spinal-Stim |
| Paragon 28, INC. | $123.47 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $121.13 | 2020-2024 | Ajovy |
| Smith+Nephew, INC. | $104.81 | 2019-2024 | Pico 14 |
| Alphatec Spine, INC | $83.98 | 2022 | |
| Alexion Pharmaceuticals, INC. | $71.59 | 2019 | |
| Zimmer Biomet Holdings, INC. | $50.26 | 2023 | Zimmer Periarticular Locking Plate System |
| Kyowa Kirin, INC. | $42.87 | 2023-2024 | Crysvita |
| Eisai INC. | $42.59 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.32 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $29.29 | 2019 | |
| Wright Medical Technology, INC. | $27.36 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.55 | 2023 | Gattex |
| Vertical Pharmaceuticals, LLC | $23.17 | 2020 | |
| Lundbeck LLC | $22.84 | 2022 | |
| Greenwich Biosciences, INC. | $22.36 | 2021 | |
| Linvatec Corporation | $21.92 | 2019 | |
| Baxter Healthcare | $20.11 | 2023 | Floseal |
| Solventum Corporation | $18.04 | 2025 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice, Activ.A.C. |
| Averitas Pharma INC. | $17.64 | 2025 | Qutenza |
| Impel Pharmaceuticals LLC | $16.34 | 2025 | Trudhesa |
| Molnlycke Health Care US, LLC | $15.36 | 2023 | Mepilex Border Post-Op Ag, Mepilex Border Sacrum, Mepilex Border Flex |
| Medtronic, INC. | $14.78 | 2023 | Unid_pass |
| Supernus Pharmaceuticals, INC. | $14.57 | 2022 | |
| Amneal Pharmaceuticals LLC | $12.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Deignan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.